This review has summarized the molecular functions of key BC-associated CPGs, namely, BRCA1, BRCA2, PALB2, ATM, BARD1, CHEK2, RAD51C, and RAD51D, as well as the clinical management of individuals harboring GPVs in these genes. This evidence concerns the gene BRCA2 and breast cancer.